Enzyme Acquires Myso Finance and Expands to Solana in Major 2024 Growth

Asset managers running strategies across centralized exchanges, DeFi protocols, and multiple wallets face a critical challenge: accurate reporting. Inconsistent data sources make it difficult to provide reliable valuations to investors. **The Solution** Enzyme has partnered with [1Token](https://enzyme.finance/blog-posts/enzyme-and-1token-partnership?utm_source=x&utm_medium=organic&utm_content=post) to address this problem: - Reconciles data from both CeFi and DeFi sources - Provides unified valuation across multiple venues - Helps managers maintain investor confidence through transparent reporting This follows Enzyme's recent integration with Octav, showing a pattern of building infrastructure for cross-chain and multi-venue asset management. **Why It Matters** As crypto strategies become more complex, spanning different chains and platforms, accurate position tracking becomes essential for institutional adoption and investor trust.

On-chain spot markets are narrowing the price gap with traditional venues while maintaining self-custody and instant settlement advantages. **Key developments:** - Capital efficiency improving through faster block times and enhanced execution infrastructure - Trading volume expanding as tooling matures - Institutional participants now actively monitoring the space **Market context:** This follows 3x year-over-year growth in USDC's share of spot trading volume through September 2025. Stablecoins are increasingly powering settlement and providing 24/7 market liquidity beyond traditional banking hours. The shift represents a tangible evolution from theoretical concepts to operational reality in capital markets infrastructure.

**Enzyme Onyx** addresses different protocol needs across three key stages: - **Pre-TGE**: Early participation incentives to build community - **Post-TGE**: Strengthen Total Value Locked (TVL) after token launch - **Mature stage**: Manage liquidity across multiple assets including stablecoins and liquid staking tokens The platform provides structured, on-chain strategies that protocols can adopt when timing is right for their development phase. Each stage requires different tooling approaches, but most protocols eventually need comprehensive on-chain financial infrastructure. [Explore Onyx](https://enzyme.finance/products/onyx?utm_source=x&utm_medium=organic&utm_content=post)

**Multi-chain complexity solved**: As investment products expand across different blockchains, reporting becomes increasingly complex for asset managers. **Automated data sourcing**: Chainlink's CRE (Crypto Reporting Engine) automatically pulls and verifies NAV and performance data from: - On-chain sources - Centralized finance platforms - Traditional financial systems **Pain point addressed**: The solution eliminates manual reporting work that previously required tracking assets across multiple chains and platforms. **Verification built-in**: All data is automatically verified, reducing errors and ensuring accuracy for compliance and investor reporting.

Enzyme.Myso is advancing DeFi with institutional-grade on-chain options trading. The platform offers: - Native on-chain options strategies - Fully auditable transaction flows - Infrastructure designed for DAOs and institutions **Real-world implementation**: Compound DAO recently integrated covered calls into their treasury strategy using Enzyme.Myso, targeting approximately 15% APY while maintaining controlled risk exposure. This development signals a shift in how DAOs can optimize idle capital through sophisticated options strategies. *Learn more at* [Enzyme Finance](http://enzyme.finance/products/myso)